Smartphone Health Assessment for Relapse Prevention in Early Psychosis (SHARP)  is an international, multi-site study that involves patients, family members, and clinicians in adapting LAMP (Learn, Assess, Manage, Prevent) and assessing its real-world use in predicting and preventing relapse. The observational study will be conducted by teams at 3 research sites - the Beth Israel Deaconess Medical Center in Boston, MA, the All India Institute of Medical Sciences (AIIMS) and Sangath in Bhopal, India, and the National Institute of Mental Health and Neuroscience (NIMHANS) in Bangalore, India. Spanning rural and urban settings and low to middle income patient populations, these institutions are a microcosm for the global population living with schizophrenia.

At each site, 25 patients with early course schizophrenia will be offered use of LAMP to assess mood, cognition and symptoms over the course of a year. Predicting and preventing relapse presents a crucial opportunity and first step to improve outcomes and reduce the care gap for persons living with schizophrenia. SHARP will inform the development of a scalable and sharable digital health solution to monitor the personal risk of relapse. The results of this project will inform digital tools to help address pervasive challenges in global mental health.

To read more about the project visit: Sharp | Sangath